Synopsys
SNPS
310 hedge funds and large institutions have $5.63B invested in Synopsys in 2014 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 123 increasing their positions, 103 reducing their positions, and 20 closing their positions.
147% more call options, than puts
Call options by funds: $254K | Put options by funds: $103K
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
35% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 20
19% more repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 103
2% more funds holding
Funds holding: 303 → 310 (+7)
3% more capital invested
Capital invested by funds: $5.48B → $5.63B (+$146M)
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$58M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$46.2M |
| 3 |
O
OppenheimerFunds
New York
|
-$35.6M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$16.4M |
| 5 |
TGA
Trilogy Global Advisors
Winter Park,
Florida
|
-$15.8M |
SNPS Hedge Fund Activity: Q3 2014 in Review
310 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Synopsys (SNPS) for Q3 2014, worth a combined $5.63B — up 2.7% from $5.48B a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new SNPS positions and 20 closed out — a net gain of 7 holders — while 123 added to existing stakes and 103 trimmed.
The largest buyer was BlackRock Institutional Trust, adding an estimated $24M. The largest seller was Fidelity Investments, cutting an estimated $58M.
- 310 institutional investors held Synopsys (SNPS) as of Q3 2014, up from 303 in Q2 2014.
- Funds reported $5.63B of Synopsys stock for Q3 2014, up 2.7% quarter-over-quarter.
- 27 funds opened new Synopsys positions in Q3 2014 and 20 closed out, a net change of +7 holders.
- The largest Synopsys buyer in Q3 2014 was BlackRock Institutional Trust, an estimated $24M added.
- The largest Synopsys seller in Q3 2014 was Fidelity Investments, an estimated $58M sold.
Based on aggregated 13F filings for Q3 2014.